Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Midsona AB (publ), Audiocast, Q3'26

By Inderes10/22/2026, 9:00 AM
Midsona

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Henrik Hjalmarsson
00:02 - 22:10

Good morning, everybody, and welcome to the presentation of Midsona's third quarter 2026 interim report. My name is Henrik Hjalmarsson and I am the President and CEO. And with me, I have Niclas Lundin, CFO. We will spend the coming 20 minutes or so going through an overview of the quarter, as well as a deep dive into the financials by Niclas Lundin, after which there will be plenty of time for questions. But for those of you who are new to us, just a quick introduction to Midsona. So we are a European natural and healthy food group, and we are positioned in categories with clearly structurally growing demand driven by health and sustainability trends. We combine a strong local brand platform with a scalable group of European brands, and we have a vision to become a leading European player within natural and healthy foods. We have sales of roughly 3.6 billion SEK for the last 12 months, with a 4.3% EBIT margin, roughly 700 employees in seven European countries, and 50 own brands. And starting then with a summary of the third quarter. And I thought we would use the boxes here on the right-hand side to go through the overview of the quarter. So total sales grew by 1.7% in the quarter, driven largely by the acquisition of Risenta in Sweden that we completed earlier in the year. And total organic growth, however, was -3.7%, driven mainly by a sales decline in contract manufacturing, where we're consistently optimizing for improved profitability, but also partially by own consumer brands, which declined by 0.2% organically, then mainly driven by the development in Division North. I will come back to that as we continue. EBIT margin was stable year-over-year, leading to an EBIT growth of 1 MSEK to 46 million, and that was fueled by a gross margin expansion of 0.3 percentage points to 29%, which in turn was driven by a better mix. However, with a slightly negative net price-cost arbitrage, which I will also come back to in a little bit. And the EBIT was also negatively impacted by increased investments in marketing and a one-off credit loss in the Nordics. The investments in marketing, however, are clearly in line with our strategy to fuel our brands for continued profitable growth. Finally, cash flows continue to improve to 57 million, an improvement of 9 million year-over-year, which led us to a net debt to adjusted EBITDA of one, a considerable improvement versus the same time last year. If we look then briefly at the year-to-date numbers. The, uh. So, for the first three quarters of the year, we have seen continued strength in profitability and growth in our own consumer brands. So net sales have had a 2.1% decline year-to-date organically. However, again, this was driven mainly by contract manufacturing, partially linked to the fire in Spain that we had during last year, but also by continuously optimizing our contract manufacturing business to drive margin. However, that's been mitigated by growth in our own consumer brands, which have grown by 0.7% organically so far in the year. If we look on the profit side, EBIT has strengthened considerably. First nine months by 25 million to 111 million, which corresponds to an EBIT margin growth of 0.9 percentage points to 4.1%. That is again driven by a gross margin expansion, which is driven mainly by mix, partially the growth in own consumer brands and a decline in contract manufacturing, but also through improved overall efficiency, partially linked to the cost-saving program that we launched at the back end of last year. And although we have also seen increased investments in marketing during the first nine months, which has a slight negative impact on our EBIT in the short term, it is very good and in line with our strategy for the longer-term cash flow. Also, for the first nine months, there was a clear improvement versus last year. And again, this leaves us in a very good position in terms of our balance sheet. Looking then briefly at the development in the different divisions in the third quarter, we saw, starting with the Nordics, an organic sales growth of -3%. However, own consumer brands grew positively at 1.9%, while total organic sales growth was negative, largely driven by a decline in contract manufacturing. Gross margin was slightly down by 0.1 percentage points, temporarily pressured by rising prices for transport and packaging, which have yet to be recovered in prices to the customer and consumer. And hence a slightly reduced EBIT margin, partially linked to the gross margin, but also with increased investments in marketing and the one-off credit loss that we saw in the Nordics, however, partly mitigated by overhead cost savings linked to the cost-saving program. Looking then at Division North, we had a tough third quarter with weak sales and an organic change of -10.3%, driven largely by own consumer brands, but also own B2B brands, which have lost some of the transition momentum. The gross margin saw a decline, mainly driven by a negative mix move as we had a more negative sales development for own consumer brands than we did for contract manufacturing, and the consequential EBIT margin declined, mainly related to a lower fixed cost coverage or a negative operational leverage development, as we saw a sales decline in the quarter. Lastly, in Division South, with a more positive development continuing the year-over-year profit improvements, with the organic sales increasing by 10.2%, largely driven by licensed brands, but also some of the own brands developing strongly and more profitable contract manufacturing in France. Own consumer brands in total came in flat year over year. However, it is fueled by continued strong growth in the French grocery trade. While we have some more challenges in the French health food stores business, we have a materially improved gross margin, driven by continued efficiency improvements and an improved sales mix. Looking instead from a portfolio perspective by category, starting with the organic products where we had a total organic sales development of -2%. However, we did see growth in our own consumer brands, where the marketing and innovation initiatives and the investments we are doing in our brands are paying off for several brands with strong organic growth. I will come back to one such example in a little bit. However, there were also some challenges, particularly in Division North. But we should also recognize that the unusually hot summer in continental Europe has impacted the total category negatively, with actually total industry-wide negative growth numbers during at least the first half of the quarter. As consumer habits have been impacted by the heat wave. And the brand growth is still not enough to compensate for contract manufacturing development, which was partially impacted by the fire in Spain, but also the previously alluded to optimization for profit. Looking at Health Foods, we saw organic growth of -7%, which was driven by the optimization of contract manufacturing. On the branded side, we saw a mixed picture. A mixed picture with several brands performing well, such as Friggs. I will come back to that. While some brands face challenges, we have seen the Risenta brand off to a strong start as a fairly new part of the group, contributing to structural growth. Lastly, on the Consumer Health side, we saw an organic sales growth of -3%, with some key brands lagging behind our growth plans. That requires additional focus to drive the implementation of the strategy and the growth trajectory. Again, I will come back to that. And some brands were negatively impacted on a top-line perspective by a conscious optimization for profit. I just want to provide one example of the initiatives we are doing on the Consumer Health side, gathering our strong Consumer Health proposition with our strongest brand, Friggs, bringing supplements to the masses. So, we are launching a new range. And these are just a few examples of mass-market-focused, relatable products, very much in line with popular and growing niches. So focusing on very popular and highly growing products, like, for example, creatine, but in a very approachable format, chewable tablets, and under the mainstream and very approachable brand Friggs, we are launching this into the grocery trade. So we are gaining access to the mass market with a very positive initial reception from both customers and consumers. So we're excited by the opportunities that this launch starts to open up, bringing trendy products into a more approachable and mass market format. I also thought I'd relate back to the point I made about the strong growth that we see in parts of the organic portfolio, where we're doing a very good job leveraging a strong local position. So the Helios brand in Norway is a good example where we have, over the past two years, achieved strong growth in combination with increased profitability thanks to successfully leveraging clean eating interest and trends with agile innovation, marketing plans, and very disciplined omnichannel execution. So really proving that the logic and the structure of the strategy is right and when successfully implemented, drives strong results. I'm also pleased to see that while we are pleased with the profit improvement of 1 million SEK in the quarter and are pleased with the strength of the underlying cash flows. We're not happy with the total progress we're making in the quarter, and we think that the performance is insufficient. Our ambitions are considerably higher than the growth that we achieved in the quarter. But structurally, we are still happy to see that we are, in a longer-term perspective, making clear progress towards our targets with material improvement on both the organic growth of our own consumer brands, our EBIT margin, as well as our leverage over the past couple of years. And with that said, a few points on our short-term priorities to continue that trajectory and accelerate it even further. First of all, and most obviously, we are looking at turning around the development in the Division North after a tough quarter. So accelerating improvement, focusing with a focused revamp of our brand proposition, as well as a cost overview to continue to optimize the business. We are working on accelerating the strategy implementation on the Consumer Health portfolio. I mentioned one example of this just a little while ago, but we see a material opportunity to accelerate the growth in this category with the strong starting point that we have. And then lastly, make sure that we maintain the positive momentum on several brands. Again, I mentioned one of those, Helios, just recently, but we have several strong brands in the organic and health portfolio where we also have a positive development that we want to continue to accelerate. With that, I'm going to hand over to Niclas Lundin, who's going to take you through the details of the financials. Thank you, Henrik, and let me start with the financial summary for the quarter. Net sales were up by 15 MSEK, including a Risenta impact of 40 MSEK. Adjusting for currency impact. Total organic growth came in at -3.7%, in line with Henrik's earlier comments. Total gross margin improved by 0.3 percentage points, mainly from improved sales mix. With the gradual and deliberate shift from sales of lower profit contract manufacturing to higher profit own consumer brands. In consequence, EBIT improved by 1 million SEK with an unchanged EBIT margin of 5.0%. And apart from the increased gross margin, we saw a clear positive impact on EBIT from the cost reduction program initiated in 2025. This was, however, partly offset by increased sales and marketing initiatives, as well as a larger bad debt provision in Norway. The financial net continued to improve versus last year this quarter, by 9 million to plus 2 million, which during this quarter was mainly driven by positive currency effects. But we also see the longer-term positive impact from more favorable conditions in the new financing agreement, as well as lower indebtedness. Net result landed on 39 MSEK, taking net IAC of plus 1 MSEK into consideration. IAC during the quarter was mainly made up of received insurance compensation related to business interruption insurance in Spain, plus 7 MSEK, and costs related to a fraud incident, -5 MSEK. This incident has led to a further reinforcement of the internal control environment, and we hope that most of the loss will be covered by the group's insurance. This is, however, not yet reflected in the accounts. Cash flow from operating activities came in at 57 MSEK, which was an improvement of 9 million versus last year. About one-third of the improvement was related to the P&L, and two-thirds were related to changes in working capital. And the quarter ended with a leverage of 1.0 times. A substantial improvement versus last year, where we stood at 1.6. Now moving over to the sales development for the quarter. And as already mentioned, net sales increased by 50 MSEK, equivalent to 1.7%. Structural growth from Risenta contributed 40 million MSEK and FX effects an additional 8 million MSEK. In consequence, the organic sales development was negative, with -33 MSEK, equivalent to -3.7%. It is worth noting that 90% of the organic sales decline is referable to contract manufacturing and business-to-business sales. That is, parts of our business where we have taken a strategic decision to phase out and gradually replace contracts with low profitability. And this development for contract manufacturing and business-to-business is also visible in the graph on the right, where we see a double-digit organic decline for both contract manufacturing and business-to-business. Our contract manufacturing business showed a decline in Division Nordics and Division North, respectively, mainly related to the discontinued low-profit contracts. But in Division South, contract manufacturing sales increased, mainly related to new and more profitable contracts in France, and the B2B branded business in Germany is still under transition to focus on profit over volumes. In Q3, we saw a positive effect on margin. However, volumes of new, more profitable contracts were not enough to compensate for the replaced contracts. Old contracts. The license business declined by 2.2%, mainly referable to. Certain Consumer Health brands in the Nordics offering seasonal products. And to round off the net sales analysis, our own consumer brands came in with a slightly negative organic growth of -0.2% for the quarter. Besides a few exceptions, in particular related to Division North, we generally see good sales development for our larger prioritized brands, most of them within our organic product range. But there is also good progress for our largest brand, Friggs, within the health food category. And in line with what Henrik previously touched upon, on a rolling 12-month basis, organic growth of our own consumer brands portfolio has improved by 3.7 percentage points versus Q3 last year. Okay, so let's head over to the quarterly EBIT development compared to last year. Higher volumes and improved gross margin jointly resulted in 4 million more gross profit. This improvement, including the impact of Risenta and FX-adjusted, was mainly driven by a favorable sales mix. Sales, marketing, and administration expenses increased by 7 MSEK net, also including Risenta impact. We now see the full effect of our cost reduction program for 2025. This positive impact was, however, largely offset by increased investments in direct sales and marketing activities to facilitate future profitable growth, and OpEx in Q3 were also negatively impacted by a bad debt provision of 3 MSEK related to a customer in Norway going into reconstruction. The majority of other income of 2 MSEK came from the sale of equipment, and the effect from translation and revaluation was 2 MSEK compared to last year. And to conclude, EBIT landed at 46 MSEK, which was an improvement of 1 MSEK, with an unchanged EBIT margin of 5.0%. On the right-hand side table, we illustrate the quarterly and the rolling 12-month EBIT development during the last two years. And it's encouraging to see the gradual improvement with rolling 12 EBITDA increasing to 158 MSEK this quarter end, which is 36 MSEK higher than by the end of September last year. And consequently, rolling 12 EBIT margin has improved from 3.3% to 4.3%. Let's continue to the quarterly cash flow. In Q3, we saw a continued buildup of inventory, partly seasonal. However, on a substantially lower level than in Q2 and much in line with Q3 last year. Receivables increased during the quarter, in part due to higher sales volumes and following the same seasonal pattern as in 2025. This negative working capital impact was partly offset by an increase in payables, in part related to renegotiated and improved supplier credit terms. To summarize, the operating cash flow landed at 57 MSEK, an improvement by 9 MSEK versus last year. As previously mentioned, about one-third of the improvement was related to the P&L, and two-thirds were related to changes in working capital. The right-hand side illustrates the cash flow trend, displaying an increase of rolling 12-month operating cash flow by 68 million compared to Q3 2025, up to 254 million. So we're approaching the end of the Financial Review, summarizing our cash and debt situation. The quarter ended with 789 MSEK in available cash, an increase of 44 MSEK versus last quarter and plus 133 MSEK versus Q3 last year. And available cash now represents 22% of the last 12 months' sales, which is a very healthy level. And finally, let's look at the net debt situation. In Q3. IFRS 16 related debt increased by some 30 million due to new rental contracts. Taking IFRS 16 related net debt to 132 million. Despite this increase, total net debt decreased by 16 MSEK to 301 MSEK during the quarter. And this means a continued historically low net debt in relation to adjusted EBITDA, including Risenta pro forma effect of 1.0 times, and an equivalent of 0.7 times excluding IFRS 16 effects. The current leverage is well within our financial target. Establishing our strong financial position going forward. That wraps up the financial review. And back to you, Henrik.

Niclas Lundin
22:11 - 22:16

Yes. Thank you very much. So, with that, we will open up for questions. Over to you. Operator.

Operator
22:17 - 22:35

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Alice Beer from ABG Sundal Collier. Please go ahead.

Alice Beer
22:36 - 22:40

Hi Henrik and Niclas. Thank you for the presentation. Can you hear me?

Henrik Hjalmarsson
22:40 - 22:41

Yes, yes.

Alice Beer
22:42 - 22:57

Great. You mentioned at the start that packaging and transport costs are rising and that raw materials could follow this autumn. How much of the price increases you require have been accepted by retailers, and how long of a lag should we expect before prices catch up?

Niclas Lundin
22:59 - 23:54

Hi, Alice. Good question. Most of those factors vary a bit by geography, in all fairness. And most of those negotiations or discussions are actually ongoing right now. But if we look at the situation as it stands now, we remain fairly optimistic to get coverage for what we see so far. However, we should recognize that given the unusually hot summer and the geopolitical situation, there is a risk that we will see more inflation coming through as the full impact on harvests is seen during this harvest period. So far, we are quite optimistic about getting through what we see, to protect the margins. But partially that remains to be seen as we see the impacts on the rest of the harvest.

Alice Beer
23:55 - 24:09

Okay, great. Thank you for the clarity, and moving on to contract manufacturing in the Nordics. How much of this low-margin volume has led to exits, and how much of the fixed costs in the production facilities can you adjust and when?

Niclas Lundin
24:11 - 25:25

Yeah. I think there is less and less to do, as that has been a conscious strategy over the past year or so to both perform a thorough analysis and the optimization of the portfolio. And there might be some small parts still to optimize, but less so than what we have seen here in the past couple of quarters. And we have done some good fixed cost optimization. In all fairness, we also have to recognize that even from a fixed cost coverage perspective, some of the contracts we've exited were questionable in terms of their marginal contribution. But what I will add is there is an important piece of the puzzle here. This relates particularly to one manufacturing site in the Nordics. And that is also the manufacturing site where we are moving the Risenta production. The Risenta production insourcing is part of the solution and the optimization of this puzzle. So basically, very simply put, we are exiting low-margin contract manufacturing business to give room for production of our own consumer brand in the shape of Risenta.

Alice Beer
25:27 - 25:39

Great. Thank you. You talked about more transformative alternatives for Spain. Is a divestment being actively marketed? And what is the book value and run-rate loss attached to the Spanish operation?

Niclas Lundin
25:41 - 26:45

No. A marketing of the business is not actively pursued. And when we talk about longer-term transformative alternatives. I think here and now, we are very committed to driving the business into profitable growth and positive cash flows, and longer term, the fullest broad spectrum of alternatives is available in terms of upping the investment levels further to accelerate the growth. The vast majority of what we manufacture and market in Spain is tofu and tempeh, and that is a category on a European basis that is growing very rapidly. And. But there could also be all the way to, you know, partial divestment alternatives. But there is nothing actively marketed at this point. I think the second question we cannot really answer off the top of our heads. We will have to come back to you separately on that.

Alice Beer
26:46 - 26:58

Okay. Fair. Moving on to the brand portfolio review, how many of the tail brands are candidates? I mean, what share of sales do they represent, and what impairment risk sits on the brand intangibles?

Niclas Lundin
26:59 - 27:02

Sorry, can you repeat that? We lost you for a second. Could you please repeat that?

Alice Beer
27:03 - 27:15

Yes, of course. On the brand portfolio review, how many of the tail brands are candidates, what share of sales do they represent, and are there any impairment risks associated with the brand intangibles?

Niclas Lundin
27:16 - 28:20

I think that it is a bit too early to give a quantified response to your question. We are in a very structural shareholder value generation or capital allocation optimization perspective, reviewing the full breadth of the business. There are some potential tail brands that might be, how should I say? Easier to execute from that perspective. But they will not have a material impact. At least in the short term, they will have a longer-term positive impact on our profitability. Otherwise we would not take action. But they won't have material short-term impact. Neither on the balance sheet nor on the income statement, I would say, but that perspective might change as we deepen the analysis. And then we will have to come back to that during the next quarter.

Alice Beer
28:22 - 28:30

Okay, great. And then marketing spend is flagged as a margin drag again. What is the sequential increase, and when do you expect the volume payback?

Niclas Lundin
28:32 - 29:48

Yeah. The sequential increase here in percent is, I would say, material. If you look at the percentage of marketing spend in terms of margin impact, it is not that material. Actually less than 0.1 percentage points. Oh well, it is less than 0.1 percentage points in total in the quarter. So it is impacting the margin, but not that materially in the quarter. And we do expect to establish a new level. It has gradually increased a bit and we expect it to continue to gradually increase a little bit more before we believe that we reach a level where it is sustainably driving profitable growth for our brands, but it is not like we are expecting a doubling from the current level or anything like that. So we expect another marginal increase, and it could be of the order of upwards of another 0.1 percentage points or so, or maybe even, sorry, a bit more than that. Yes, it is a bit more than that. Probably another half percent maybe or something like that, that we would expect to see.

Alice Beer
29:50 - 30:03

Okay. And just a final question for me. Q4 is seasonally the largest quarter, but Christmas volumes are being rationalised. And what is the expected revenue impact of that in Q4 2026 versus Q4 2025?

Niclas Lundin
30:05 - 30:56

Yes, specifically regarding the Christmas volumes, we do not expect a material impact compared to what we saw last year. So we did see an impact last year. We are not expecting to see that material further impact this year. And so we don't think that, obviously, I think in terms of turning around that question. If you look at the trajectory specifically regarding own brand development, we expect to maintain and accelerate the momentum of the brands that have a good position. And the key answer to your question in terms of assessing the outcome will be how quickly we can stabilize and then turn around the development, particularly for Division North on the sales side, but we don't expect a material year-over-year impact on the Christmas volume side versus last year.

Alice Beer
30:58 - 31:10

Okay. I understand that this might be a hard follow-up question to answer, but how quickly can you do that? What is the sort of base case we are talking about? Is it possible to see that effect in a quarter, or should we think more like a year?

Niclas Lundin
31:11 - 32:07

I think we can see results if we start from the bottom. So we can see results quite quickly. I mean, this was new news, obviously, that we did lose some listings in one mainstream retail operator that was quite important to us in the business here in the third quarter. If we start from the bottom, we can quite quickly start to adapt the cost base and take action to stabilize and improve the profit development. When it comes to. And then we can also do what I would call tactical commercial initiatives on both the own brand side, but also on the contract manufacturing side. To get a strong foundation that will stabilize the development and achieve a full, strong momentum swing is something that will take quarters rather than months.

Alice Beer
32:09 - 32:10

Okay. Great. Thank you.

Niclas Lundin
32:12 - 32:23

There is a lot to be done, from the bottom up of the P&L, to compensate and mitigate for the development even before the full impact of that. Okay.

Alice Beer
32:25 - 32:26

Great. Perfect.

Niclas Lundin
32:29 - 32:30

Thank you.

Operator
32:31 - 32:37

There are no more questions at this time. So I hand the conference back to the speakers for any closing comments.

Niclas Lundin
32:39 - 32:48

Okay. Thank you very much, everybody for listening in. We thereby close this conference. Thank you. Bye bye.

Henrik Hjalmarsson
32:49 - 32:49

Bye bye.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…